“Efficacy and Safety of Tralokinumab with Concomitant Topical Corticosteroids in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of the ECZTRA 3 Trial” (2020) SKIN The Journal of Cutaneous Medicine, 4(6), p. s97. doi:10.25251/skin.4.supp.97.